Testing an APA practice guideline: Symptom-targeted medication utilization for patients with borderline personality disorder

Journal of Psychiatric Practice

Volumn 10, Issue 3, 2004, Pages 156-161

  Oldham, John M ^a,f   Bender, Donna S ^b   Skodol, Andrew E ^b   Dyck, Ingrid R ^c   Sanislow, Charles A ^d   Yen, Shirley ^c   Grilo, Carlos M ^d   Shea, M Tracie ^c   Zanarini, Mary C ^e   Gunderson, John G ^e   McGlashan, Thomas E ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Affective dysregulation; Borderline personality disorder; Cognitive perceptual symptoms; Impulsive behavioral dyscontrol; Medications; Personality disorders; Practice guidelines; Treatment algorithms

Indexed keywords

ANTICONVULSIVE AGENT; CLONAZEPAM; LITHIUM; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR DISORDER; BORDERLINE STATE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SOCIETY; MOOD DISORDER; PERCEPTION DISORDER; PRACTICE GUIDELINE; PREDICTION; PUBLICATION; SYMPTOM; UNITED STATES;

ADOLESCENT; ADULT; AFFECT; BORDERLINE PERSONALITY DISORDER; COGNITION DISORDERS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; SOCIETIES, MEDICAL; UTILIZATION REVIEW;

EID: 2442677780     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200405000-00003     Document Type: Article

References (21)

1. Skodol AE, Gunderson JG, McGlashan TM, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry 2002;159:276-83.
2. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001;158:295-302.
3. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001;158(Suppl):1-52.
4. Soloff PH. Symptom-oriented psychopharmacology for personality disorders. Journal of Practical Psychiatry and Behavioral Health 1998;4:3-11.
5. Gunderson JG, Shea MT, Skodol AE, et al. The Collaborative Longitudinal Personality Disorders Study: Development, aims, design, and sample characteristics. J Personal Disord 2000;14:300-15.
6. Hollingshead AB, Redlich FC. Schizophrenia and social structure. Am J Psychiatry 1954;110:695-701.
7. Zanarini MC, Frankenburg FR, Sickel AE, et al. Diagnostic Interview for DSM-IV Personality Disorders. Belmont, MA: McLean Hospital, Laboratory for the Study of Adult Development; 1996.
8. Zanarini MC, Skodol AE, Bender D, et al. The Collaborative Longitudinal Personality Disorders Study: Reliability of Axis I and II diagnoses. J Personal Disord 2000;14:291-9.
9. Keller M, Nielson E. Longitudinal Interval Follow-Up Evaluation Adapted for Personality Disorders Study. Providence, RI: Brown University School of Medicine, Department of Psychiatry and Human Behavior; 1989.
10. Sanislow CA, Grilo CM, Morey LC, et al. Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: Findings from the Collaborative Longitudinal Personality Disorders Study. Am J Psychiatry 2002;159:284-90.
11. SAS Version 8.2. Cary, NC: SAS Institute; 2001.
12. Hosmer DW, Lemeshow S. Assessing the fit of the model. In: Applied logistic regression. New York: John Wiley & Sons; 1989:135-75.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th Edition. Washington, DC: American Psychiatric Association; 1994:32.
14. McGlashan TH, Grilo CM, Skodol AE, et al. The Collaborative Longitudinal Personality Disorders Study: Baseline Axis I/II and I/II diagnostic co-occurrence. Acta Psychiatr Scand 2000;102:256-64.
15. Tyrer P. Practice guideline for the treatment of borderline personality disorder: A bridge too far. J Personal Disord 2002;16:113-8.
16. Paris J. Commentary on the American Psychiatric Association Guidelines for the Treatment of Borderline Personality Disorder: Evidence-based psychiatry and the quality of evidence. J Personal Disord 2002;16:130-4.
17. Zanarini MC, Frankenburg FR, Khera GS, et al. Treatment histories of borderline inpatients. Compr Psychiatry 2001;42:144-50.
18. Keller MB, Lavori PW, McDonald-Scott P, et al. The reliability of retrospective treatment reports. Psychiatry Res 1983;9:81-8.
19. Keller MB, Klerman GL, Lavori PW, et al. Treatment received by depressed patients. JAMA 1982;248:1848-55.
20. Goisman RM, Rogers MP, Steketee, GS, et al. Utilization of behavioral methods in a multicenter anxiety disorders study. J Clin Psychiatry 1993;54:213-8.
21. Posternak MA, Zimmerman M. How accurate are patients in reporting their antidepressant treatment history? J Affect Disord 2003;75:115-24.